Can "negative" be positive?

Molecular Therapy

Volumn 5, Issue 4, 2002, Pages 338-339

  Steele, Fintan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN; ONCOPROTEIN; RECOMBINANT PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE MODEL; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSARCOMA; GENE SEQUENCE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS; SCID MOUSE; TREATMENT FAILURE; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0036228636     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0574     Document Type: Note

References (10)

1. Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells
2. Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia
3. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
4. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
5. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
6. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
7. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
8. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
9. Inhibitory effect of full-length human endostatin on in vitro angiogenesis
10. Soluble recombinant endostatin purified from Escherichia coli: Antiangiogenic activity and antitumor effect